Literature DB >> 19249160

Salivary alpha-amylase as a non-invasive biomarker for the sympathetic nervous system: current state of research.

U M Nater1, N Rohleder.   

Abstract

Development of new biomarkers is a constantly evolving field of research endeavor in psychoneuroendocrinology. Salivary biomarkers have received special attention since they are readily accessible and easily obtained. Salivary alpha-amylase (sAA) has been proposed as a sensitive biomarker for stress-related changes in the body that reflect the activity of the sympathetic nervous system (SNS), and a growing body of research is accumulating to support the validity and reliability of this parameter. However, questions remain to be answered before sAA can be accepted as an index of SNS activity. This review describes sAA as an emerging biomarker for stress and provides an overview of the current literature on stress-related alterations in sAA. It critically discusses how sAA might reflect changes in the autonomic nervous system. Finally, current and future fields for the application of sAA measurement are outlined.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19249160     DOI: 10.1016/j.psyneuen.2009.01.014

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  293 in total

Review 1.  Frontiers in the use of biomarkers of health in research on stress and aging.

Authors:  Jennifer R Piazza; David M Almeida; Natalia O Dmitrieva; Laura C Klein
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2010-07-20       Impact factor: 4.077

2.  Pupil and salivary indicators of autonomic dysfunction in autism spectrum disorder.

Authors:  Christa J Anderson; John Colombo; Kathryn E Unruh
Journal:  Dev Psychobiol       Date:  2012-05-29       Impact factor: 3.038

3.  Individual differences in biological stress responses moderate the contribution of early peer victimization to subsequent depressive symptoms.

Authors:  Karen D Rudolph; Wendy Troop-Gordon; Douglas A Granger
Journal:  Psychopharmacology (Berl)       Date:  2010-05-28       Impact factor: 4.530

4.  Salivary alpha-amylase and cortisol among pentecostals on a worship and nonworship day.

Authors:  Christopher Dana Lynn; Jason Paris; Cheryl Anne Frye; Lawrence M Schell
Journal:  Am J Hum Biol       Date:  2010 Nov-Dec       Impact factor: 1.937

5.  Correlation of salivary alpha amylase level and adenotonsillar hypertrophy with sleep disordered breathing in pediatric subjects.

Authors:  Chan-Soon Park; Christian Guilleminault; Hong-Jin Park; Jin-Hee Cho; Heung-Ku Lee; Hye-Lim Son; Se-Hwan Hwang
Journal:  J Clin Sleep Med       Date:  2014-05-15       Impact factor: 4.062

6.  Correlation of Clinical and Histopathological Grades in Oral Submucous Fibrosis Patients with Oxidative Stress Markers in Saliva.

Authors:  C V Divyambika; S Sathasivasubramanian; G Vani; A J Vanishree; N Malathi
Journal:  Indian J Clin Biochem       Date:  2017-09-13

7.  Diurnal profiles of salivary cortisol and alpha-amylase change across the adult lifespan: evidence from repeated daily life assessments.

Authors:  Urs M Nater; Christiane A Hoppmann; Stacey B Scott
Journal:  Psychoneuroendocrinology       Date:  2013-09-17       Impact factor: 4.905

8.  A Social Neuroscience Perspective on Stress and Health.

Authors:  Keely A Muscatell; Naomi I Eisenberger
Journal:  Soc Personal Psychol Compass       Date:  2012-12-02

9.  Challenges in Obtaining and Assessing Salivary Cortisol and α-Amylase in an Over 60 Population Undergoing Psychotherapeutic Treatment for Complicated Grief: Lessons Learned.

Authors:  Jesse M Bell; Tina M Mason; Harleah G Buck; Cindy S Tofthagen; Allyson R Duffy; Maureen W Groër; James P McHale; Kevin E Kip
Journal:  Clin Nurs Res       Date:  2020-11-20       Impact factor: 2.075

10.  Sex-specific effects of intranasal oxytocin on autonomic nervous system and emotional responses to couple conflict.

Authors:  Beate Ditzen; Urs M Nater; Marcel Schaer; Roberto La Marca; Guy Bodenmann; Ulrike Ehlert; Markus Heinrichs
Journal:  Soc Cogn Affect Neurosci       Date:  2012-07-27       Impact factor: 3.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.